Target intelligence / Profile preview

AGBL4 intronic transcript 1 (non-protein coding) (AGBL4-IT1)

Target: AGBL4-IT1
Molecular classification: Long non-coding RNA (lncRNA), Non-protein coding transcript

Overview

AGBL4 intronic transcript 1 (AGBL4-IT1) is a long non-coding RNA gene annotated as non-protein coding and transcribed from the intronic region of the AGBL4 protein-coding gene on chromosome 1. Its RNA product, like other lncRNAs, is presumed to have potential regulatory roles in gene expression, but its specific biological functions, disease associations, and molecular mechanisms remain uncharacterized in current literature and genomic annotation resources. This transcript is distinct from the protein-coding AGBL4 gene, which encodes a metallocarboxypeptidase involved in tubulin modification, but there are no documented functional or therapeutic implications for AGBL4-IT1.

Other names: AGBL4-IT1AGBL4 intronic transcript 1 (non-protein coding)

Mechanism of action

Not applicable. No therapeutics or mechanism of action established for AGBL4-IT1

Biological functions

Putative regulatory function in gene expression at the RNA level, as is typical for lncRNAsSpecific functions for AGBL4-IT1 are currently uncharacterized in the literature or genomic databases

Disease associations

Not clearly established. There is no direct evidence implicating AGBL4-IT1 in specific human diseases based on available annotation

Safety considerations

None reported. As there are no known drugs targeting this lncRNA or clear disease associations, there are no specific safety concerns described

Interacting drugs

None reported

Biomarkers

None reported for AGBL4-IT1 in clinical or preclinical contexts

Beyond the preview

Go deeper on AGBL4 intronic transcript 1 (non-protein coding) (AGBL4-IT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AGBL4 intronic transcript 1 (non-protein coding) (AGBL4-IT1).

Explore the full profile